Optimizing mRNA delivery with targeted elastin-like polypeptide–based LENN formulations: Insights into the endocytosis mechanism
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2502486122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Saloni Darji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Multidisciplinary Cancer Research Facility, Purdue University, West Lafayette, IN 47907. Hauptthemen laut MEDLINE: Endocytosis, RNA, Messenger, Elastin, Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
Gene delivery has emerged as a groundbreaking technique for altering gene expression, offering new possibilities in treating a vast array of diseases. We report a layer-by-layer elastin-like polypeptide nucleic acid nanoparticle (LENN) system for mRNA delivery as an attractive alternative to viral vectors and lipid nanoparticle (LNP) systems. This study focuses on determining the physical characteristics of LENN bearing mRNA cargo and assessing their biological performance in T24 bladder tumor cells. Our data show that mRNA encoding luciferase forms stable 30 to 130 nm LENN particles via batch mixing to efficiently encapsulate the mRNA strands, are resistant to heparin challenge, and are capable of storage at −20 °C for 3 d as lyophilized powders while retaining full biological activity after rehydration. We also demonstrate that LENN targeted to the epidermal growth factor receptor (EGFR) can efficiently deliver the mRNA cargo to the cytosol of EGFR+ T24 human bladder cancer cells via clathrin-mediated endocytosis where it is translationally active. Lipid profiling analyses show the significant role that upregulated phospholipid biosynthesis plays in nanoparticle internalization and endosomal escape compared to untargeted LENN, indicating the importance of the clathrin pathway in contributing to the delivery efficiency of LENN. Endocytosis inhibition experiments further support the involvement of the clathrin pathway. These findings highlight the compelling features of LENN with respect to their size, in vitro and in vivo targetability, mRNA encapsulation efficiency, complex stability, gene expression, and “green” manufacturability, offering an attractive alternative to existing methods for gene delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Multidisciplinary Cancer Research Facility, Purdue University, West Lafayette, IN 47907.
- Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907.
- Department of Comparative Pathobiology, Multidisciplinary Cancer Research Facility, Purdue University, West Lafayette, IN 47907.
ORCID-Profile: Saloni Darji, Feng Qu, Christina R Ferreira, David H Thompson
Förderung
- NCI NIH HHS
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Darji, S., Qu, F., Henager, M., Prasad, A., Elzey, B. D., Ferreira, C. R., & Thompson, D. H. (2026). Optimizing mRNA delivery with targeted elastin-like polypeptide–based LENN formulations: Insights into the endocytosis mechanism. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2502486122
Vancouver
Darji S, Qu F, Henager M, Prasad A, Elzey BD, Ferreira CR, et al. Optimizing mRNA delivery with targeted elastin-like polypeptide–based LENN formulations: Insights into the endocytosis mechanism. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2502486122
BibTeX
@article{Darji2026,
author = {Darji, Saloni and Qu, Feng and Henager, Marissa and Prasad, Ankita and Elzey, Bennett D and Ferreira, Christina R and Thompson, David H},
title = {Optimizing mRNA delivery with targeted elastin-like polypeptide–based LENN formulations: Insights into the endocytosis mechanism},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2502486122}
}
EUVIMED